<DOC>
	<DOC>NCT01693120</DOC>
	<brief_summary>VICTORY AF is an IDE, prospective global, multi-center, single arm, controlled, unblinded, investigational clinical study. The purpose of this clinical study is to evaluate the risk of procedure and/or device related strokes in subjects with persistent or long-standing persistent atrial fibrillation (AF) undergoing ablation with the Phased RF System.</brief_summary>
	<brief_title>Evaluation of the Phased Radio Frequency Ablation System</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>History of symptomatic persistent or longstanding persistent atrial fibrillation Failure of at least one antiarrhythmic drug Structural heart disease Prior ablation in left atrium for AF Known sensitivities (or allergy) to heparin, warfarin, contrast media Contraindicated for MRI Invasive cardiovascular procedure performed or planned within 3 month period of ablation procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>ablation</keyword>
	<keyword>atrial fibrillation</keyword>
	<keyword>Radio frequency</keyword>
</DOC>